СПИСОК ЛИТЕРАТУРЫ

1. Poon, LC, Yang H, Lee JC, et al. ISUOG Interim Guidance on 2019 novel coronavirus infection during pregnancy and puerperium: information for healthcare professionals. Ultrasound Obstet Gynecol. 2020. doi: 10.1002/uog.22013.

2. Белокриницкая Т.Е., Шаповалов К.Г. Грипп и беременность. - ГЭОТАР-Медиа, 2015. - 144 с.

3. Wong SF, Chow KM, Leung TN, et al. Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome. Am J Obstet Gynecol, 2004, 191(1): 292 - 297.

4. Alfaraj SH, Al-Tawfiq JA, Memish ZA. Middle East respiratory syndrome coronavirus (MERS-CoV) infection during pregnancy: report of two cases & review of the literature. J Microbiol Immunol Infect 2019; 52: 501 - 503.

5. https://www.who.int/news-room/q-a-detail/q-a-on-COVID-19-pregnancy-childbirth-and-breastfeeding.

6. Breslin N, Baptiste C, Gyamfi-Bannerman C, et al. COVID-19 infection among asymptomatic and symptomatic pregnant women: Two weeks of confirmed presentations to an affiliated pair of New York City hospitals. Am J Obstet Gynecol MFM 2020.

7. Liu D et al. Pregnancy and Perinatal Outcomes of Women With Coronavirus Disease (COVID-19) Pneumonia: A Preliminary Analysis. AJR Am J Roentgenol. 2020 Mar 18: 1 - 6. doi: 10.2214/AJR.20.23072.

8. Белокриницкая Т.Е., Артымук Н.В., Филиппов О.С., Шифман Е.М. Динамика эпидемического процесса и течение новой коронавирусной инфекции COVID-19 у беременных Дальневосточного и Сибирского федеральных округов. Гинекология. 2020; 22(5): 6 - 11. DOI: 10.26442/20795696.2020.5.200439

9. Белокриницкая Т.Е., Артымук Н.В., Филиппов О.С., Фролова Н.И. Клиническое течение, материнские и перинатальные исходы новой коронавирусной инфекции COVID-19 у беременных Сибири и Дальнего Востока. Акушерство и гинекология. 2021; 2: 48 - 54.

10. Liu H, Wang LL, Zhao SJ, Kwak-Kim J, Mor G, Liao AH. Why are pregnant women susceptible to COVID-19? An immunological viewpoint. J Reprod Immunol. 2020; 139: 103 - 122.

11. Khan MMA, Khan MN, Mustagir MG, Rana J, Haque MR, Rahman M.M. COVID-19 infection during pregnancy: a systematic review to summarize possible symptoms, treatments, and pregnancy outcomes. medRxiv. 2020. 10.1101/2020.03.31.20049304

12. Yan J, Guo J, Fan C, et al. Coronavirus disease 2019 (COVID-19) in pregnant women: a report based on 116 cases. Am J Obstet Gynecol. 2020; 223(1): 111.e1 - 111.e14.

13. Chen L, Li Q, Zheng D, et al. Clinical characteristics of pregnant women with Covid-19 in Wuhan, China. N Engl J Med. 2020; 382(25): e100.

14. Collin J, Bystrom E, Carnahan A, Ahrne M. Pregnant and postpartum women with SARS-CoV-2 infection in intensive care in Sweden. Acta Obstet Gynecol Scand. 2020 May 9. doi: 10.1111/aogs.13901.

15. Jafari M., Pormohammad A., Sheikh Neshin S.A., Ghorbani S., Bose D., Alimohammadi S., Basirjafari S., Mohammadi M., Rasmussen-Ivey C., Razizadeh M.H., Nouri-Vaskeh M., Zarei M.. Clinical characteristics and outcomes of pregnant women with COVID-19 and comparison with control patients: A systematic review and meta-analysis. Rev Med Virol. 2021 Jan 2: e2208. doi: 10.1002/rmv.2208. Epub ahead of print. PMID: 33387448.

16. Diriba K, Awulachew E, Getu E. The effect of coronavirus infection (SARS-CoV-2, MERS-CoV, and SARS-CoV) during pregnancy and the possibility of vertical maternal-fetal transmission: a systematic review and meta-analysis. Eur J Med Res. 2020 Sep 4; 25(1): 39. doi: 10.1186/s40001-020-00439-w. PMID: 32887660; PMCID: PMC7471638.

17. Vallejo V, Ilagan JG. A Postpartum Death Due to Coronavirus Disease 2019 (COVID-19) in the United States. Obstet Gynecol. 2020 May 8. doi: 10.1097/AOG.0000000000003950.

18. Coronavirus (COVID-19) Infection in Pregnancy. Version 12: RCOG, 14.10.2020. 77 p.

19. Schwartz DA. An Analysis of 38 Pregnant Women with COVID-19, Their Newborn Infants, and Maternal-Fetal Transmission of SARS-CoV-2: Maternal Coronavirus Infections and Pregnancy Outcomes [published online ahead of print, 2020 Mar 17]. Arch Pathol Lab Med

20. Capobianco G., Saderi L., Aliberti S., Mondoni M., Piana A., Dessole F., et al. COVID-19 in pregnant women: A systematic review and meta-analysis [published online ahead of print, 2020 Jul 16]. Eur J Obstet Gynecol Reprod Biol. 2020; S0301-2115(20)30446-2. doi: 10.1016/j.ejogrb.2020.07.006

21. Белокриницкая Т.Е., Артымук Н.В., Филиппов О.С., Шифман Е.М. Особенности течения COVID-19 у беременных Дальнего Востока и Сибири. Проблемы репродукции. 2020; 26(3): 85 - 91. DOI: 10.17116/repro20202603185

22. Методические рекомендации по кодированию и выбору основного состояния в статистике заболеваемости и первоначальной причины в статистике смертности связанных с COVID-19. Методические рекомендации. Минздрав России. Версия 2. 02.07.2021. - 24 с.

23. Анестезиолого-реанимационное обеспечение пациентов с новой коронавирусной инфекцией COVID-19. Методические рекомендации Общероссийской общественной организации "Федерации Анестезиологов-реаниматологов", версия N 5 от 26 февраля 2021 года). - 242 с.

24. Vlachodimitropoulou Koumoutsea, E., Vivanti, A.J., Shehata, N., Benachi, A., Le Gouez, A., Desconclois, C., Whittle, W., Snelgrove, J. and Malinowski, K.A. (2020), COVID-19 and acute coagulopathy in pregnancy. J Thromb Haemost. Accepted Author Manuscript.

25. Gungor Baris et al. Elevated D-dimer levels on admission are associated with severity and increased risk of mortality in COVID-19: A systematic review and meta-analysis. The American journal of emergency medicine. 2021; 39: 173 - 179. doi: 10.1016/j.ajem.2020.09.018

26. Thachil J, Tang N, Gando S, et al. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost 2020 [Epub ahead of print] DOI: doi: 10.1111/jth.14810.81.

27. Demi L, Demi M, Smargiassi A, Inchingolo R, Faita F, Soldati G. Ultrasonography in lung 183 pathologies: new perspectives. Multidiscip Respir Med. 2014 May 9; 9(1): 27. doi: 184 10.1186/2049-6958-9-27.185.

28. Smargiassi A, Inchingolo R, Soldati G et al. The role of chest ultrasonography in the management of respiratory 187 diseases: document II. Multidiscip Respir Med. 2013 Aug 9; 8(1): 55. doi: 10.1186/2049-6958-8-18855.189.

29. Zanforlin A, Giannuzzi R, Nardini S et al. The role of chest ultrasonography in the management of respiratory 191 diseases: document I. Multidiscip Respir Med. 2013 Aug 9; 8(1): 54. doi: 10.1186/2049-6958-8-19254.193.

30. Ye X, Xiao H, Chen B, Zhang S. Accuracy of Lung Ultrasonography versus Chest Radiography 197 for the Diagnosis of Adult Community-Acquired Pneumonia: Review of the Literature and 198 Meta-Analysis. PLoS One. 2015 Jun 24; 10(6): e0130066. doi: 10.1371/journa.

31. Reissig A, Copetti R, Mathis G et al. Lung ultrasound in the diagnosis and follow-up of community-acquired 202 pneumonia: a prospective, multicenter, diagnostic accuracy study. Chest. 2012 Oct; 142(4): 965 - 203 972. doi: 10.1378/chest.12-0364.

32. Inchingolo R, Smargiassi A, Momile e et al. Look at the bng: can chest ultrasonography be useful in pregnancy f Multidiscip Respir 206 Med. 2014 Jun в; 9(1): 32. doi: 10.1186/2049-6958-9-32.eCollection 2014.

33. Buonsenso D, Moro F, Inchingolo R, Smargiassi A, Demi L, Soldati G, Moroni R, Lanzone A, Scambia G, Testa AC. Effectiveness of a 'fast lung ultrasound teaching program for gynecologists/obstetricians dealing with pregnant women with suspicion of COVID-19.

34. Hu L, Wang C. Radiological role in the detection, diagnosis and monitoring for the coronavirus disease 2019 (COVID-19). Eur Rev Med Pharmacol Sci. 2020 Apr; 24(8): 4523 - 4528. doi: 10.26355/eurrev_202004_21035.

35. Liu H, Liu F, Li J, Zhang T, et al. Clinical and CT imaging features of the COVID-19 pneumonia: Focus on pregnant women and children. J Infect. 2020 Mar 20. pii: S0163-4453(20)30118-3.

36. СанПиН 2.6.1.1192-03 Гигиенические требования к устройству и эксплуатации рентгеновских кабинетов, аппаратов и проведению рентгенологических исследований.

37. Mathur S, Pillenahalli Maheshwarappa R, Fouladirad S, Metwally O, et al. Emergency Imaging in Pregnancy and Lactation. Can Assoc Radiol J. 2020 Mar 11:846537120906482.

38. С.П. Морозов, Д.Н. Проценко, С.В. Сметанина [и др.]//Серия "Лучшие практики лучевой и инструментальной диагностики". - Вып. 65. - М.: ГБУЗ "НПКЦ ДиТ ДЗМ", 2020. - 78 с.

39. Синицын В.Е., Тюрин И.Е., Митьков В.В. Временные согласительные методические рекомендации Российского общества рентгенологов и радиологов (РОРР) и Российской ассоциации специалистов ультразвуковой диагностики в медицине (РАСУДМ) "Методы лучевой диагностики пневмонии при новой коронавирусной инфекции COVID-19" (версия 2). Вестник рентгенологии и радиологии. 2020. Том 101. N 2. 72 - 89.

40. S. Inui et al. Radiology: Cardiothoracic Imaging. 8 April 2020, с модификациями.

41. Arentz M, Yim E, Klaff L, et al. Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State. JAMA. Published online March 19, 2020.

42. Juusela Alexander, Nazir Munir, Gimovsky Martin. Two Cases of COVID-19 Related Cardiomyopathy in Pregnancy. American Journal of Obstetrics & Gynecology. 3 April 2020, In Press, Journal Pre-proof.

43. А.И. Гус, Т.А. Ярыгина, М.П. Шувалова Ультразвуковая диагностика в акушерстве в условиях пандемии COVID-19. Акушерство и гинекология N 5 2020.

44. Chen, D., Yang, H., Cao, Y., Cheng, W., Duan, T., Fan, C., & He, J. (2020). Expert consensus for managing pregnant women and neonates born to mothers with suspected or confirmed novel coronavirus (COVID-19) infection. International Journal of Gynecolo.

45. Abu-Rustum, R.S., Akolekar, R., Sotiriadis, A., Salomon, L.J., Da Silva, C.F., Wu, Q., Poon, L.C. (2020). ISUOG Consensus Statement on organization of routine and specialist obstetric ultrasound services in the context of COVID-19. Ultrasound in obstetric.

46. Приказ Минздрава России от 19.03.2020 N 198 "О временном порядке организации работы медицинских организаций в целях реализации мер по профилактике и снижению рисков распространения новой коронавирусной инфекции COVID-19" (в редакции приказов Минздрава России от 27.03.2020 N 246н, от 18.05.2020 N 459н, от 29.05.2020 N 513н, от 07.07.2020 N 686н, от 27.08.2020 N 905н, от 15.09.2020 N 1140н, от 30.10.2020 N 1184н, от 04.12.2020 N 1288н, от 23.03.2021 N 232н, от 22.07.2021 N 792н).

47. Постановление Главного государственного санитарного врача РФ от 22.05.2020 N 15 (ред. от 04.12.2021) "Об утверждении санитарно-эпидемиологических правил СП 3.1.3597-20 "Профилактика новой коронавирусной инфекции (COVID-19)"

48. Байбарина Е.Н., Филиппов О.С., Гусева Е.В., Белокриницкая Т.Е., Шаповалов К.Г., Шифман Е.М., Куликов А.В., Хаитов Р.М., Лусс М.П., Сухих Г.Т., Адамян Л.В., Пырегов А.В., Малеев В.В. Грипп и вызванная им пневмония у беременных: этиотропная и респираторная терапия, акушерская тактика, профилактика. Информационно-методическое письмо Министерства здравоохранения РФ от 28.12.2016.

49. Updated SOGC Committee Opinion - COVID-19 in Pregnancy (March 13th).

50. Boseley S. China trials anti-HIV drug on coronavirus patients. The Guardian. February 7, 2020. https://www.theguardian.com/world/2020/feb/07/china-trials-anti-hiv-drugcoronavirus-patients. Accessed March 7, 2020.

51. Rasmussen SA, Smulian JC, Lednicky JA, Wen TS, Jamieson DJ. Coronavirus Disease 2019 (COVID-19) and pregnancy: what obstetricians need to know. Am J Obstet Gynecol 2020 Feb 24.

52. https://www.acog.org//media/project/acog/acogorg/files/advocacy/letters/patien t-centered-care-for-pregnant-patients-during-the-covid-19pandemic.pdf?la=en&hash=B1C126841E86BA4A69547BE518BA9047.

53. D'Souza R. et al. Pregnancy and COVID-19: pharmacologic considerations. Ultrasound Obstet Gynecol. 2021 Feb; 57(2): 195 - 203. doi: 10.1002/uog.23116

54. World Health Organization. Clinical management of severe acute respiratory infection when COVID-19 is suspected. 13 March 2020. https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov).

55. Куликов А.В., Шифман Е.М. Анестезия, интенсивная терапия и реанимация в акушерстве и гинекологии. Клинические рекомендации. Протоколы лечения. Издание четвертое, дополненное и переработанное/Под редакцией А.В. Куликова, Е.М. Шифмана. Медицина. 2017: 672.

56. https://www.rlsnet.ru/tn_index_id_14719.htm#primenenie-pri-beremennosti-i-kormlenii-grud%60yu

57. Horby Peter W., et al. Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet. 2020; 396: 1345 - 1352

58. Singh Bhagteshwar, et al. Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19. The Cochrane Database of Systematic Reviews 2020; 4

59. Gupta Shruti, et al. Association between early treatment with tocilizumab and mortality among critically ill patients with COVID-19. JAMA internal medicine. 2021; 181(1): 41 - 51.

60. Kotak Sohny, et al. Use of Tocilizumab in COVID-19: a systematic review and meta-analysis of current evidence. Cureus. 2020; 12(10).

61. Briggs G, Freeman R, Towers C, Forinash A. Drugs in Pregnancy and Lactation, 11th edn. Philadelphia: Lippincott Williams & Wilkins; 2017.

62. Giampreti A, Eleftheriou G, Gallo M, Butera R, Contessa G, Faraoni L, Sangiovanni A, Negri G, Falchi G, Bacis G. Medications prescriptions in COVID-19 pregnant and lactating women: the Bergamo Teratology Information Service experience during COVID-19 outbreak in Italy. J Perinat Med. 2020 Nov 26; 48(9): 1001 - 1007. doi: 10.1515/jpm-2020-0339. PMID: 33055313.

63. Malgie Jishnu, Jan W. Schoones, and Bart G. Pijls. Decreased mortality in coronavirus disease 2019 patients treated with tocilizumab: a rapid systematic review and meta-analysis of observational studies. Clinical Infectious Diseases. 2020.

64. Narang Kavita, et al. SARS-CoV-2 infection and COVID-19 during pregnancy: a multidisciplinary review. Mayo Clinic Proceedings. Elsevier, 2020.

65. Lambelet Valentine, et al. SARS-CoV-2 in the context of past coronaviruses epidemics: Consideration for prenatal care. Prenatal diagnosis. 2020; 40(13): 1641 - 1654.

66. Favilli Alessandro, et al. Effectiveness and safety of available treatments for COVID-19 during pregnancy: a critical review. The Journal of Maternal-Fetal & Neonatal Medicine. 2020: 1 - 14.

67. Louchet Margaux, et al. Placental transfer and safety in pregnancy of medications under investigation to treat COVID-19. American journal of obstetrics & gynecology MFM. 2020: 100159.

68. Временные методические рекомендации. Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19). Минздрав России. Версия 13.1 (17.11.2021) - 236 с.

69. University of Oxford. RECOVERY trial, interim results 2020 [https://www.recoverytrial.net/ results]. Accessed 2021 Feb 12.

70. RECOVERY Collaborative Group. Dexamethasone in hospitalized patients with Covid-19. New England Journal of Medicine. 2021; 384(8): 693 - 704.

71. Saad Antonio F., et al. Corticosteroids in the management of pregnant patients with coronavirus disease (COVID-19). Obstetrics & Gynecology. 2020; 136(4): 823 - 826.

72. Клинические рекомендации. Преждевременные роды. Ходжаева З.С., Шмаков Р.Г., Адамян Л.В., Артымук Н.В. и соавт. 2020

73. Parazzini, F., Bortolus, R., Mauri, P.A., Favilli, A., Gerli, S., & Ferrazzi, E. (2020). Delivery in pregnant women infected with SARS CoV 2: A fast review. International Journal of Gynecology & Obstetrics https://doi.org/10.1002/ijgo.13166.

74. Saad AF, Chappell L, Saade GR, et al. Corticosteroids in the Management of Pregnant Patients With Coronavirus Disease (COVID-19). Obstet Gynecol 2020; 136: 823 - 6.

75. Clinical Trials. Randomised Evaluation of COVID-19 Therapy (RECOVERY) 2020 [Available from: https://clinicaltrials.gov/ct2/show/NCT04381936] accessed 2020 Jul 20.

76. Royal College of Obstetricians & Gynaecologists. Coronavirus (COVID-19) Infection in Pregnancy, 2020. https://www.rcog.org.uk/en/guidelines-research-services/guidelinescoronavirus-pregnancy/.

77. D'Souza R, I, Teshler L, Acharya G, Hunt BJ, McLintock C. Acritical review of the pathophysiology of thrombotic complications and clinical practice recommendations for thromboprophylaxis in pregnant patients with COVID-19. Acta Obstet Gynecol Sca.

78. Halscott T, Vaught J. Management Considerations for Pregnant Patients With COVID-19 Society for Maternal Fetal Medicine; 2020.

79. Lim W, Dentali F, Eikelboom JW, Crowther MA. Meta-analysis: low-molecular-weight heparin and bleeding in patients with severe renal insufficiency. Ann Intern Med. 2006 May 2; 144(9): 673 - 84. 88.

80. Gian CarloDi RenzoMD, PhD Irene Giardina MD, PhD Coronavirus disease 2019 in pregnancy: consider thromboembolic disorders and thromboprophylaxis American Journal of Obstetrics and Gynecology 22 April 2020.

81. Gulersen Moti, et al. Coronavirus Disease 2019 (COVID-19)-related multisystem inflammatory syndrome in a pregnant woman. Obstetrics and gynecology. 2021; 137(3): 418.

82. Herth Felix JF, George Sakoulas, and Fadi Haddad. Use of Intravenous Immunoglobulin (Prevagen or Octagam) for the Treatment of COVID-19: Retrospective Case Series. Respiration. 2020: 1 - 9.

83. Tang, Man Wai, Erfan Nur, and Bart J. Biemond. Immune thrombocytopenia due to COVID-19 during pregnancy. American journal of hematology. 2020; 95(8): E191 - E192

84. Royal College of Obstetricians & Gynaecologists et al. Coronavirus (COVID-19) Infection in Pregnancy. RCOG. Version 14.2: Published Monday 6 December 2021. https://www.rcog.org.uk/globalassets/documents/guidelines/2021-12-06-coronavirus-covid-19-infection-in-pregnancy-v14.2.pdf

85. https://www.sotrovimab.com/content/dam/cf-pharma/hcp-sotrovimab-phase2/en_US/sotrovimab-fda-letter-of-authorization.pdf

86. Drugs and Lactation Database (LactMed) [Internet] https://www.ncbi.nlm.nih.gov/books/NBK571318/

87. Siemieniuk R. A. C. et al. Antibody and cellular therapies for treatment of covid-19: a living systematic review and network meta-analysis//bmj. - 2021. - Т. 374. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459162/

88. Cheng Q. et al. Efficacy and safety of current medications for treating severe and non-severe COVID-19 patients: an updated network meta-analysis of randomized placebo-controlled trials//Aging. - 2021. - Т. 13. - N. undefined. https://www.aging-us.com/full/203522

89. Gupta A. et al. Early Covid-19 Treatment With SARS-CoV-2 Neutralizing Antibody Sotrovimab//medRxiv. - 2021 https://www.medrxiv.org/content/10.1101/2021.05.27.21257096v1

90. Пресс-релиз FDA от 26 мая 2021 г. "Coronavirus (COVID-19) Update: FDA Authorizes Additional Monoclonal Antibody for Treatment of COVID-19"//https://www.fda.gov

91. The COVID-19 Treatment Guidelines Panel's Statement on the Emergency Use Authorization of Bamlanivimab for the Treatment of COVID-19//COVID-19 Treatment Guidelines. - U. S. National Institutes of Health, 2020. - 18 ноября. - Дата обращения: 18.11.2020.

92. https://www.regeneron.com/downloads/treatment-covid19-eua-fact-sheet-for-hcp.pdf

93. Elisabeth Mahase. Covid-19: FDA authorises neutralising antibody bamlanivimab for non-admitted patients (англ.)//BMJ. - 2020. - 11 November (vol. 371). - ISSN 1756 - 1833. - doi:10.1136/bmj.m4362.

94. Robert L. Gottlieb, Ajay Nirula, Peter Chen, Joseph Boscia, Barry Heller. Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19 (англ.)//JAMA. - 2021-02-16. - Vol. 325, iss. 7. - P. 632. - ISSN 0098 - 7484. - doi: 10.1001/jama.2021.0202.

95. Bartlett R.H., Ogino M.T., Brodie D., et al. Initial ELSO Guidance Document: ECMO for COVID-19 Patients with Severe Cardiopulmonary Failure. ASAIO J. 2020 Mar 30. DOI: 10.1097/MAT.0000000000001173

96. ELSO COVID-19 Interim Guidelines (2020). https://www.elso.org/Portals/0/Files/pdf/guidelines%20elso%20covid%20for%20web_Final.pdf

97. ELSO. Guidance Document: ECMO for COVID-19 Patients with Severe Cardiopulmonary Failure. 23 March 2020. http://covid19.elso.org

98. Brodie D., Slutsky A.S., Combes A. Extracorporeal Life Support for Adults With Respiratory Failure and Related Indications: A Review. JAMA. 2019; 322(6): 557 - 568.

99. Vasques F., Romitti F., Gattinoni L., Camporota L. How I wean patients from veno-venous extra-corporeal membrane oxygenation. Critical Care. 2019; 23(1): 316.

100. Broman Lars M., et al. Weaning from veno-venous extracorporeal membrane oxygenation: how I do it. Journal of thoracic disease 10. Suppl 5. 2018: 692.

101. Aissaoui N., Luyt C.E., Leprince P., et al. Predictors of successful extracorporeal membrane oxygenation (ECMO) weaning after assistance for refractory cardiogenic shock. Intensive Care Med. 2011; 37(11): 1738 - 1745.

102. Zhao W, Zhong Z, Xie X, Yu Q, Liu J. Itehtion Between Chen CT Findings and Clinical Conditions of Coronavirus Disease (COVID-19) Pnemnonia: A Multicenter Study [published online ahead of print, 2020 Mar 3]. AJR Am J Roentgenol. 2020; 1 - 6. doi: 10.2414/AJR.20.

103. Favre G, Pomar L, Qi X, Nielsen-Saines K, Musso D, Baud D. Guidelines for pregnant women with suspected SARS-CoV-2 infection. Lancet Infect Dis 2020. DOI: 10.1016/S1473-3099(20)30157-2.

104. Poon LC, et al. ISUOG Safety Committee Position Statement: safe performance of obstetric and gynecological scans and equipment cleaning in the context of COVID-19. Ultrasound Obstet Gynecol 2020; 13: 287 - 288.

105. Balakrishnan, Ashokka, et al. Care of the pregnant woman with covid-19 in labor and delivery: anesthesia, emergency cesarean delivery, differential diagnosis in the acutely ill parturient, care of the newborn, and protection of the healthcare personnel. 2020. https://www. ncbi. nlm. nih. gov/pmc/articles/PMC7151436/pdf/main. pdf

106. Приказ Минздравсоцразвития РФ от 03.12.2007 N 736 "Об утверждении перечня медицинских показаний для искусственного прерывания беременности" (в ред. 27.12.2011).

107. Амбулаторное обследование и ведение беременных женщин с подозрением или подтвержденным COVID-19. Алгоритм ACOG/SMFM, 2020.

108. American College of Obstetricians and Gynecologists. Practice Advisory: Novel Coronavirus 2019 (COVID-19). https://www.acog.org/Clinical-Guidance-andPublications/Practice-Advisories/Practice-Advisory-Novel Coronavirus2019?IsMobileSet=false. Accessed March.

109. Организация оказания медицинской помощи беременным, роженицам, родильницам и новорожденным при новой коронавирусной инфекции COVID-19. Методические рекомендации. Минздрав России. Версия 4. 05.07.2021. - 121 с.

110. Coronavirus (COVID-19) Infection in Pregnancy Information for healthcare professionals. Version 7: Published Thursday 9 April 2020 - 54 p.

111. Li Y, Xia L. Coronavirus Disease 2019 (COVID-19): Role of Chest CT in Diagnosis and Management [published online ahead of print, 2020 Mar 4]. AJR Am J Roentgenol. 2020; 1 - 7. doi: 10.2214/AJR.20.22954 36.

112. Zhao W, Zhong Z, Xie X, Yu Q, Liu J. Relation Between Chest CT Findings and Clinical Conditions of Coronavirus Disease (COVID-19) Pneumonia: A Multicenter Study [published online ahead of print, 2020 Mar 3]. AJR Am J Roentgenol. 2020; 1 - 6. doi: 10.2214/AJR.

113. Ai T, Yang Z, Hou H, et al. Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases. Radiology 2020 Feb 26.

114. Ferrazzi E, Frigerio L, Savasi V et al. Vaginal delivery in SARS-CoV-2 infected pregnant women in Northern Italy: a retrospective analysis. BJOG. 2020 Apr 27. doi: 10.1111/1471-0528.16278.

115. Ди Ренцо Д.К., Макацария А.Д., Цибизова В.И., Капанна Ф., Разеро Б., Комличенко Э.В., Первунина Т.М., Хизроева Д.Х., Бицадзе В.О., Шкода А.С. О принципах работы перинатального стационара в условиях пандемии коронавируса. Вестник РАМН. 2020; 75(1): 83 - 92. do.

116. Di Toro F, Gjoka M, Di Lorenzo G, et al. Impact of COVID-19 on maternal and neonatal outcomes: a systematic review and meta-analysis. Clin Microbiol Infect. 2021; 27(1): 36 - 46. doi: 10.1016/j.cmi.2020.10.007

117. Pountoukidou A., Potamiti-Komi M., Sarri V., Papapanou M., Routsi E., Tsiatsiani A. M., Vlahos N., Siristatidis C. Management and Prevention of COVID-19 in Pregnancy and Pandemic Obstetric Care: A Review of Current Practices. Healthcare (Basel, Switzerland). 2021; 9(4), 467. https://doi.org/10.3390/healthcare9040467

118. Chen, R., Zhang, Y., Huang, L. et al. Safety and efficacy of different anesthetic regimens for parturients with COVID-19 undergoing Cesarean delivery: a case series of 17 patients. Can J Anest.

119. Bauer Melissa; Bernstein Kyra; Dinges Emily; Delgado Carlos et al. Obstetric Anesthesia During the COVID-19 Pandemic. Anesthesia & Analgesia. April 6, 2020 h/J Can Anesth (2020).

120. Capanna F, Haydar A, McCarey C, Bernini Carri E, Bartha Rasero J, Tsibizova V, Helmer H, Makatsarya A, Di Renzo GC. Preparing an obstetric unit in the heart of the epidemic strike of COVID-19: quick reorganization tips. J Matern Fetal Neonatal Med. 2020 A.

121. Donders, Francesca, et al. ISIDOG recommendations concerning COVID-19 and pregnancy. Diagnostics. 2020; 10(4): 243.

122. Mei H, Hu Y. Characteristics, causes, diagnosis and treatment of coagulation dysfunction in patients with COVID-19]. Zhonghua Xue Ye Xue Za Zhi. 2020 Mar 5; 41(0): E002.

123. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020 Apr; 18(4): 844 - 847.

124. World Health Organization (WHO). Coronavirus disease (COVID-19): Breastfeeding [cited 2020 May 7]. Available from: https://www.who.int/ru/news-room/q-a-detail/q-a-on-covid-19-and-breastfeeding

125. Ronchi A, Pietrasanta C, Zavattoni M, et al. Evaluation of rooming-in practice for neonates born to mothers with severe acute respiratory syndrome coronavirus 2 infection in Italy. JAMA Pediatr. Published online December 7, 2020. doi: 10.1001/jamapediatrics.2020.5086.

126. Salvatore CM, Han J-Y, Acker KP, et al. Neonatal management and outcomes during the COVID-19 pandemic: an observational cohort study. Lancet Child Adolesc Health. 2020; 4(10): 721 - 727. doi: 10.1016/S2352-4642(20) 30235-2)

127. Bartick, M.C., , V., Giusti, A., Chapin, E.M., Bhana, N.B., , M.T., & Feldman-Winter, L. (2021). Maternal and Infant Outcomes Associated with Maternity Practices Related to COVID-19: The COVID Mothers Study. Breastfeeding Medicine, 16(3), 189 - 199. doi.org/10.1089/bfm.2020.0353

128. Anand, P., Yadav, A., Debata, P. et al. Clinical profile, viral load, management and outcome of neonates born to COVID 19 positive mothers: a tertiary care centre experience from India. Eur J Pediatr 180, 547 - 559 (2021). https://doi.org/10.1007/s00431-020-03800-7

129. Постановление Главного государственного санитарного врача Российской Федерации от 22 мая 2020 года N 15 "Об утверждении санитарно-эпидемиологических правил СП 3.1.3597-20 "Профилактика новой коронавирусной инфекции (COVID-19)" с изменениями от 04.12.2021 N 33

130. World Health Organization (WHO). Breastfeeding advice during the COVID-19 outbreak. 2020. [cited 2020 Jul 4]. Available from: http://www.emro.who.int/nutrition/nutrition-infocus/breastfeeding-advice-during-covid-19-outbreak.html.

131. American Academy of Pediatrics. FAQs: management of infants born to mothers with suspected or confirmed COVID-19. Accessed August 4, 2020. https://services.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/clinical-guidance/faqs-management-of-infantsborn-to-covid-19-mothers/

132. Kaufman, David A., and Karen M. Puopolo. "Infants Born to Mothers With COVID-19 - Making Room for Rooming-in." JAMA pediatrics (2020). doi: 10.1001/jamapediatrics.2020.5100

133. Kimberlin DW, Stagno S. Can SARS-CoV-2 infection be acquired in utero? More definitive evidence is needed. JAMA. 2020; 323(18): 1788 - 1789. doi: 10.1001/jama.2020.4868.

134. Allotey J, Stallings E, Bonet M, Yap M, Chatterjee S, Kew T et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ. 2020; 370: m3320. doi: https://doi.org/10.1136/bmj.m3320.

135. World Health Organization (WHO). COVID-19 Clinical management: living guidance. Available online: https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2021-1

136. Anand, P., Yadav, A., Debata, P. et al. Clinical profile, viral load, management and outcome of neonates born to COVID 19 positive mothers: a tertiary care centre experience from India. Eur J Pediatr 180, 547 - 559 (2021). https://doi.org/10.1007/s00431-020-03800-7

137. Fang F, Luo XP. Facing the pandemic of 2019 novel coronavirus infections: the pediatric perspectives. Chin J Pediatr 2020; 58: 81 - 5.

138. Zhang N, Wang L, Deng X, et al. Recent advances in the detection of respiratory virus infection in humans. J Med Virol 2020.

139. Trevisanuto D., Cavallin F., Cavicchiolo M.E., Borellini M., Calgaro S., Baraldi E. Coronavirus infection in neonates: a systematic review. Arch Dis Child Fetal Neonatal Ed. 2020: fetalneonatal-2020-319837. DOI: https://doi.org/10.1136/archdischild-2020-319837

140. Xing, Y.H., Ni, W., Wu, Q., Li, W.J., Li, G.J., Wang, W.D., ... & Xing, Q.S. (2020). Prolonged viral shedding in feces of pediatric patients with coronavirus disease 2019. Journal of Microbiology, Immunology and Infection. doi.org/10.1016/j.jmii.2020.03.0.

141. Zhang, T., Cui, X., Zhao, X., Wang, J., Zheng, J., Zheng, G., ... & Xu, Y. (2020). Detectable SARS-CoV-2 viral RNA in feces of three children during recovery period of COVID-19 pneumonia. Journal of Medical Virology.

142. Методические рекомендации N МР 3.1/3.5.0170/5-20 "Рекомендации по использованию и обработке защитной одежды и средств индивидуальной защиты при работе в контакте с больными COVID-19 (подозрительными на заболевание) либо при работе с биологическим материалом от таких пациентов"

143. Методические рекомендации N 3.1.0209-20 "Рекомендации по организации противоэпидемического режима в медицинских организациях при оказании медицинской помощи населению в период сезонного подъема заболеваемости острыми респираторными инфекциями и гриппом в условиях сохранения рисков инфицирования новой коронавирусной инфекцией (COVID-19)"

144. Методические рекомендации N МР 3.1/3.5.0172/1-20 "Рекомендации по применению средств индивидуальной защиты (в том числе многоразового использования) для различных категорий граждан при рисках инфицирования COVID-19"

145. Babata, Kikelomo L., et al. "Feeding strategies to prevent neonatal SARS-CoV-2 infection in term or late preterm babies born to mothers with confirmed COVID-19." Cochrane Database of Systematic Reviews 2020.2020; 7. doi: 10.1002/14651858.CD013691.

146. https://www.who.int/publications/i/item/WHO-2019-nCoV-vaccines-SAGE_recommendation-BNT162b2-2021.1

147. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/effectiveness.html

148. RANZCOG, COVID-19 Vaccination in Pregnant and Breastfeeding Women. Updated Wednesday 10 March 2021. https://ranzcog.edu.au/statements-guidelines/covid-19-statement/covid-19-vaccination-information.

149. Shimabukuro Tom T., et al. Preliminary findings of mRNA COVID-19 vaccine safety in pregnant persons. New England Journal of Medicine. 2021.

150. https://www.rcog.org.uk/en/guidelines-research-services/coronavirus-covid-19-pregnancy-and-womens-health/covid-19-vaccines-and-pregnancy/

151. Сухих Г.Т., Долгушина Н.В., Шмаков Р.Г., Климов В.А., Яроцкая Е.Л., Петрова У.Л. Исходы беременности пациенток, вакцинированных от COVID-19 во время беременности - предварительные данные. Акушерство и гинекология. 2021; 11: 5 - 8. https://dx.doi.org/10.18565/aig.2021.11

152. Stafford Irene A., Jacqueline G. Parchem, Baha M. Sibai. The coronavirus disease 2019 vaccine in pregnancy: risks, benefits, and recommendations. American Journal of Obstetrics and Gynecology. 2021; 224(5): 484 - 495

153. https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=f925ce88-9e37-45cc-b747-7966ba386b4c&t=

154. Письмо Минздрава России от 22.12.2021 N 30-4/И/2-21694 "О направлении актуализированных временных методических рекомендаций "Порядок проведения вакцинации взрослого населения против COVID-19".

155. Долгушина Н.В., Драпкина Ю.С., Кречетова Л.В., Иванец Т.Ю., Менжинская И.В., Гус А.И., Байрамова Г.Р., Сухих Г.Т. Вакцина Гам-КОВИД-Вак (Спутник V) не оказывает негативного влияния на овариальный резерв у женщин репродуктивного возраста. Акушерство и гинекология 2021; 7: 81 - 86. DOI: 10.18565/aig.2021.7.81-86

156. Драпкина Ю.С., Долгушина Н.В., Шатылко Т.В., Николаева М.А., Менжинская И.В., Иванец Т.Ю., Кречетова Л.В., Красный А.М., Гамидов С.И., Байрамова Г.Р., Сухих Г.Т. Вакцина Гам-КОВИД-Вак (Спутник V) не оказывает негативного влияния на сперматогенез у мужчин. Акушерство и гинекология 2021; 7: 88 - 94. DOI: 10.18565/aig.2021.7.88-94

157. Chahla, Rossana Elena, et al. Long-term analysis of antibodies elicited by SPUTNIK V: A prospective cohort study in , Argentina. The Lancet Regional Health-Americas. 2021: 100123.

158. Rossi, Andres H., et al. Sputnik V vaccine elicits seroconversion and neutralizing capacity to SARS-CoV-2 after a single dose. Cell Reports Medicine 2.8 2021: 100359

159. Cui Pengfei, et al. Clinical features and sexual transmission potential of SARS-CoV-2 infected female patients: a descriptive study in Wuhan, China. MedRxiv. 2020.

160. Stanley Kate E., et al. Coronavirus disease-19 and fertility: viral host entry protein expression in male and female reproductive tissues. Fertility and sterility. 2020; 114(1): 33 - 43.

161. Maya Walter D. Cardona, Stefan S. Du Plessis and Paula A. Velilla. SARS-CoV-2 and the testis: similarity with other viruses and routes of infection. Reproductive biomedicine online. 2020; 40(6): 763 - 764.

162. Chen Yun, et al. Structure analysis of the receptor binding of 2019-nCoV. Biochemical and biophysical research communications. 2020; 525(1): 135 - 140.

163. Dutta Sulagna, and Pallav Sengupta. SARS-CoV-2 and male infertility: possible multifaceted pathology. Reproductive Sciences; 28. (1): 23 - 26.

164. Sengupta P., Leisegang K., Agarwal A. The impact of COVID-19 on the male reproductive tract and fertility: A systematic review. Arab J Urol. 2021 Aug 9; 19(3): 423 - 436. doi: 10.1080/2090598X.2021

165. Holtmann Nora, et al. Assessment of SARS-CoV-2 in human semen-a cohort study. Fertility and sterility. 2020; 114(2): 233 - 238.

166. Xu Jian, et al. Orchitis: a complication of severe acute respiratory syndrome (SARS). Biology of reproduction. 2006; 74(2): 410 - 416.

167. Ma Ling, et al. Evaluation of sex-related hormones and semen characteristics in reproductive-aged male COVID-19 patients. Journal of medical virology. 2021; 93(1): 456 - 462.

168. https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2021-02/28-03-01/05-covid-Shimabukuro.pdf

169. Chen W, et al. SARS-CoV-2 Entry Factors: ACE2 and TMPRSS2 Are Expressed in Peri-Implantation Embryos and the Maternal-Fetal Interface. Engineering (Beijing). 2020 Aug 17

170. Henarejos-Castillo I., Sebastian-Leon P., Devesa-Peiro A., Pellicer A., DiazGimeno P., SARS-CoV-2 infection risk assessment in the endometrium: Viral infection-related gene expression across the menstrual cycle, Fertility and Sterility (2020), doi: https://doi.org/10.1016/j.fertnstert.2020.06.026

171. Ding T., et al. Analysis of Ovarian Injury Associated With COVID-19 Disease in Reproductive-Aged Women in Wuhan, China: An Observational Study. Front Med (Lausanne). 2021 Mar 19; 8: 635255. doi: 10.3389/fmed.2021.635255. PMID: 33816526; PMCID: PMC8017139

172. Alviggi Carlo, et al. COVID-19 and assisted reproductive technology services: repercussions for patients and proposal for individualized clinical management. Reproductive Biology and Endocrinology. 2020; 18(1): 1 - 7.

173. Vaiarelli Alberto, et al. COVID-19 and ART: the view of the Italian Society of Fertility and Sterility and Reproductive Medicine. Reproductive biomedicine online. 2020; 40(6): 755 - 759.

174. Esteves Sandro C., et al. SARS-CoV-2 pandemic and repercussions for male infertility patients: A proposal for the individualized provision of andrological services. Andrology. 2021; 9(1): 10 - 18.

175. ESHRE guidance on recommencing ART treatments. Document prepared by the ESHRE COVID-19 Working Group. Ссылка: https://www.eshre.eu/-/media/sitecore-files/Guidelines/COVID19/ESHRE-Guidance-on-Recommencing-ART-treatments_update-4052020.pdf?la=en&hash=A584F8.

176. ASRM. Patient Management and Clinical Recommendations during the Coronavirus (COVID-19) Pandemic. Update#4. Ссылка: https://www.asrm.org/Patient-Mgmt-COVID-19. Дата публикации 11.05.2020.

177. ВРТ и COVID-19. Рекомендации РАРЧ по профилактике распространения новой коронавирусной инфекции SARS-CoV-2 при проведении программ ВРТ. Ссылка: http://rahr.ru/. Дата публикации: 20.05.2020.

178. La Marca Antonio, et al. COVID-19: lessons from the Italian reproductive medical experience. Fertility and sterility. 2020; 113(5): 920.

179. Xie Yuanliang, et al. COVID-19 complicated by acute pulmonary embolism. Radiology: Cardiothoracic Imaging. 2020; 2(2): e200067.

180. Li Taisheng, Hongzhou Lu and Wenhong Zhang. Clinical observation and management of COVID-19 patients. Emerging microbes & infections. 2020; 9(1): 687 - 690

181. Vaz-Silva J. et al. The vasoactive peptide angiotensin-(1-7), its receptor Mas and the angiotensin-converting enzyme type 2 are expressed in the human endometrium. Reproductive sciences. 2009; 16(3): 247 - 256.

182. Qi Jing et al. "The scRNA-seq Expression Profiling of the Receptor ACE2 and the Cellular Protease TMPRSS2 Reveals Human Organs Susceptible to SARS-CoV-2 Infection. International Journal of Environmental Research and Public Health. 2021; 18(1): 284. Available at: https://www.biorxiv.org/content/10.1101/20.

183. Smedts Anna M. et al. Expression of an extracellular matrix metalloproteinase inducer (basigin) in the human ovary and ovarian endometriosis. Fertility and sterility. 2006; 86(3): 535 - 542.

184. Li Kailiang, and Romana A. Nowak. The role of basigin in reproduction. Reproduction. 2020; 159(2): R97 - R109. doi: 10.1530/REP-19-0268.